/People

Jonathan Hepple

Investor

Managing Partner at Rosetta Capital Ltd.

London, England, United Kingdom

Find your path to Jonathan

Sign up to see every warm intro you have to Jonathan

  • Paths you didn't know you had: your email and LinkedIn already hold routes to Jonathan. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

About

Jon Hepple is a co-founder of Rosetta Capital with over 20 years of investment experience in life sciences. He began his investment career at Rothschild Asset Management and was later a partner at Seroba Life Sciences, where he held board seats at Covagen and Opsona. He is a Senior Advisor to Oxford Science Enterprises and holds a PhD from Cambridge University.

Contact· self-published, not guessed

Invests in

Biotech

Investments

Board seats

Aprea TherapeuticsCarrick TherapeuticsCatalyst BiosciencesCovagenGlycoMimeticsMission TherapeuticsNovimmuneNucleome TherapeuticsOpsonaParatekTranzyme

Per the firm's website.

Colleagues at Rosetta Capital Ltd.

Frequently asked questions

Who is Jonathan Hepple?
Jon Hepple is a co-founder of Rosetta Capital with over 20 years of investment experience in life sciences. He began his investment career at Rothschild Asset Management and was later a partner at Seroba Life Sciences, where he held board seats at Covagen and Opsona. He is a Senior Advisor to Oxford Science Enterprises and holds a PhD from Cambridge University.
Where does Jonathan Hepple work?
Jonathan Hepple is Managing Partner at Rosetta Capital Ltd..
What does Jonathan Hepple invest in?
Jonathan Hepple invests in Biotech.
What boards does Jonathan Hepple sit on?
Jonathan Hepple holds tracked board seats at Aprea Therapeutics, Carrick Therapeutics, Catalyst Biosciences, Covagen, GlycoMimetics, Mission Therapeutics, Novimmune, Nucleome Therapeutics, Opsona, Paratek.

About this profile. Compiled from public sources — Rosetta Capital Ltd.'s own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights